AMAKEM is a healthcare practice in Hasselt. Public Limited, started on 23 July 2009, 1 establishment.

What is the address of AMAKEM?

The registered office of AMAKEM is located at Kuringersteenweg 172, 3500 Hasselt.

Is AMAKEM still active?

Yes. According to the CBE (29 October 2026) AMAKEM is active, legal situation “Normale toestand”, started on 23 July 2009.

Is AMAKEM registered on Peppol?

Yes, AMAKEM is registered on the Peppol network with ID 0208:0817285772.

What is the enterprise number of AMAKEM?

The enterprise number of AMAKEM is BE0817285772.

When was AMAKEM founded?

AMAKEM was founded on 23 July 2009.

Who are the directors of AMAKEM?

According to the 2025 annual accounts, the directors of AMAKEM are: LRM beheer, E.A. Entreprises, Orrix Management.

Is AMAKEM a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 23 July 2009; 5 annual accounts filed, latest fiscal year 2025; 3 directors known from the annual account.

How much profit did AMAKEM make in 2025?

AMAKEM recorded a loss after taxes of € 5,969 in financial year 2025.

What is the revenue of AMAKEM?

As a small company, AMAKEM is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -8,122.

AMAKEM (Public Limited) - Hasselt - BE0817285772

Dossier AMAKEM, printed on 29 October 2026 from databakkes.be/en/0817285772/amakem. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

AMAKEM from Hasselt, company number BE0817285772, closed financial year 2025 with a result of € -5,969 after tax. For that financial year AMAKEM recorded a gross margin of € -8,122 and equity of € 421,110. Compared with financial year 2024, the result moved from € 290,829 to € -5,969. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 19, 2026.

What it is worth Healthy

€ 421,110

▼ 1% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -5,969

▼ still € 290,829 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 416,285

▼ 20% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -5.1 million.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ -7,995 Gross margin 2022: € -7,995 First fiscal year in the series	€ -12,024 Gross margin 2023: € -12,024 ▼ € 4,029 vs 2022 (€ -7,995) Unfavourable step	€ 289,970 Gross margin 2024: € 289,970 ▲ € 301,994 vs 2023 (€ -12,024) Favourable step	€ -8,122 Gross margin 2025: € -8,122 ▼ € 298,092 vs 2024 (€ 289,970) Unfavourable step	▼ € 298,092
Profit after taxes	€ -8,532 Profit after taxes 2022: € -8,532 First fiscal year in the series	€ -11,796 Profit after taxes 2023: € -11,796 ▼ € 3,264 vs 2022 (€ -8,532) Unfavourable step	€ 290,829 Profit after taxes 2024: € 290,829 ▲ € 302,626 vs 2023 (€ -11,796) Favourable step	€ -5,969 Profit after taxes 2025: € -5,969 ▼ € 296,798 vs 2024 (€ 290,829) Unfavourable step	▼ € 296,798
Equity	€ 248,046 Equity 2022: € 248,046 First fiscal year in the series	€ 236,250 Equity 2023: € 236,250 ▼ 5% vs 2022 (€ 248,046) Unfavourable step	€ 427,079 Equity 2024: € 427,079 ▲ 81% vs 2023 (€ 236,250) Favourable step	€ 421,110 Equity 2025: € 421,110 ▼ 1% vs 2024 (€ 427,079) Unfavourable step	▼ 1%
Total debts	€ 0 Total debts 2022: € 0 First fiscal year in the series	€ 1,625 Total debts 2023: € 1,625 Unchanged (€ 0) Unfavourable step	€ 100,000 Total debts 2024: € 100,000 ▲ € 98,375 vs 2023 (€ 1,625) Unfavourable step	€ 0 Total debts 2025: € 0 ▼ 100% vs 2024 (€ 100,000) Favourable step	▼ 100%
Cash	€ 245,669 Cash 2022: € 245,669 First fiscal year in the series	€ 234,541 Cash 2023: € 234,541 ▼ 5% vs 2022 (€ 245,669) Unfavourable step	€ 523,243 Cash 2024: € 523,243 ▲ 123% vs 2023 (€ 234,541) Favourable step	€ 416,285 Cash 2025: € 416,285 ▼ 20% vs 2024 (€ 523,243) Unfavourable step	▼ 20%
Retained profit	€ -28,638,214 Retained profit 2022: € -28,638,214 First fiscal year in the series	€ -5,307,430 Retained profit 2023: € -5,307,430 ▲ € 23.3 million vs 2022 (€ -28,638,214) Favourable step	€ -5,116,601 Retained profit 2024: € -5,116,601 ▲ € 190,829 vs 2023 (€ -5,307,430) Favourable step	€ -5,122,569 Retained profit 2025: € -5,122,569 Unchanged (€ -5,116,601) Unfavourable step
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 100,000 Dividend 2024: € 100,000 Unchanged (€ 0) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 100,000) Unchanged	▼ 100%
Balance sheet total	€ 248,046 Balance sheet total 2022: € 248,046 First fiscal year in the series	€ 237,874 Balance sheet total 2023: € 237,874 ▼ 4% vs 2022 (€ 248,046) Unchanged	€ 527,079 Balance sheet total 2024: € 527,079 ▲ 122% vs 2023 (€ 237,874) Unchanged	€ 421,110 Balance sheet total 2025: € 421,110 ▼ 20% vs 2024 (€ 527,079) Unchanged	▼ 20%

Key figures of AMAKEM, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to AMAKEM?

What happened at AMAKEM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 19, 2026 New annual accounts for financial year 2025: loss of € 5,969 (▼ € 296,798 vs 2024). Source: NBB ↗
Jul 23, 2009 Start of the company according to the CBE. KBO
Jul 22, 2009 New establishment in Hasselt. KBO

In short

From € 8,532 loss in 2022 to € 5,969 loss in 2025.

Best year ever: 2024, with € 290,829 profit.

Paid out € 100,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

LIMBURGSE RECONVERSIE MAATSCHAPPIJ 26.8%

Participatiemaatschappij Vlaanderen 18.9%

Vesalius Biocapital II ARKIV 15.2%

The stake of LIMBURGSE RECONVERSIE MAATSCHAPPIJ, Participatiemaatschappij Vlaanderen, Vesalius Biocapital II ARKIV comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

AMAKEM

Behind AMAKEM are LRM beheer, E.A. Entreprises and Orrix Management. The shares are held by LIMBURGSE RECONVERSIE MAATSCHAPPIJ (26.8%), Participatiemaatschappij Vlaanderen (18.9%) and Vesalius Biocapital II ARKIV (15.2%).

Directors

According to the 2025 annual accounts

LRM beheer

Director · represented by Aerts Tom

Also active at: Transport Marcel Depaire, Trafuco, Beltra - B, MIJNSCHADE EN BEMALING LIMBURGS MIJNGEBIED, BlooLoc, be-DIVE, LRM Lease, RMW +62 more

E.A. Entreprises

Director · represented by Edouard Abbeloos

Orrix Management

Director · represented by Matthyssens Gaston

Shareholders

LIMBURGSE RECONVERSIE MAATSCHAPPIJ

26.8%

Participatiemaatschappij Vlaanderen

18.9%

Vesalius Biocapital II ARKIV

15.2%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Kuringersteenweg 172

3500 Hasselt

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 8 companies are registered at this address.

All companies at this address →

APOLLO CARE MANAGEMENT

€ -58,372 gross margin · 2025

Viva Scandinavia Europe

€ -2,496 gross margin · 2025

Tabanaa

€ -62,383 gross margin · 2025

Timanti

BERNARDUS CARE REAL ESTATE II

€ -2,629 gross margin · 2025

+3 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0817.285.772

VAT number

BE 0817.285.772

Registered office

Kuringersteenweg 172, 3500 Hasselt

Names & denominations

AMAKEM

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

23 July 2009

Peppol

Active · Active since 14 Aug 2025

Activities · NACE

Activiteiten van medische beeldvorming en medische laboratoria

Activiteiten van medische laboratoria

View on CBE Public ↗ Annual accounts (NBB) ↗

AMAKEM

Financials

What happened to AMAKEM?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions